Company intelligence / Profile preview

TG ImmunoPharma Co., Ltd.

Hefei, Anhui Sheng / Anhui Province, Chinatgtherapeutics.com ↗

Ownership: Private
Development stage: Commercial

Overview

TG ImmunoPharma has received FDA clearance for multiple IND applications. Its lead programs include TGI‑2/NM1F (anti-PVRIG monoclonal antibody) and TGI‑6 (bispecific antibody), both of which have entered Phase 1 clinical trials targeting advanced solid tumors. Preclinical data show strong anti-tumor activity with good safety profiles. The company has over ten pipeline products with more than half having completed preclinical studies. Three innovative drugs are expected to enter Phase I trials by end of next year.

Therapeutic areas: OncologyEndocrinologyImmunologyGastroenterologyInfectious Diseases
Modalities: Monoclonal antibodies (mAbs)Bispecific antibodiesCytokinesImmune checkpoint inhibitorsNK/T-cell engagersImmunocytokines
Industry: Biotech

Drug pipeline

3 assets

ublituximab

Commercial

Indications: Multiple sclerosis

2 more assets in the full pipeline.

Request access →

Partnerships

Actively seeking global partners for development/commercialization of its lead assets; no major partnerships disclosed yet.

Beyond the preview

Go deeper on TG ImmunoPharma Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TG ImmunoPharma Co., Ltd..

Explore the full profile